Cargando…
Advances in pharmacology. Volume 23 /
ADVANCES IN PHARMACOLOGY VOL 23.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
�1992.
|
| Colección: | Advances in pharmacology ;
v. 23 |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Advance in Pharmacology, Volume 23; Copyright Page; Contents; Contributors; Chapter 1. Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging; I. Introduction; II. Nonenzymatic Glycosylation; III. Advanced Glycosylation; IV. Biological Consequences of Advanced Glycosylation; V. Pharmacological Inhibition; VI. Conclusion; References; Chapter 2. Complex Carbohydrates in Drug Development; I. Introduction; II. Glycoconjugate Structure and Biosynthesis; III. Bioactivity and Pharmaceutical Potential of Complex Carbohydrates; IV. Conclusions and Perspectives.
- III. The Superoxide Radical: Toxicity versus ReactivityIV. The Pathological Production of Superoxide Radical; V. The Pharmacodynamics and Pharmacokinetics of the Superoxide Dismutases; VI. Chemical Modification of Superoxide Dismutases; VII. Genetic Modification of Superoxide Dismutases; VIII. Down Syndrome and the Concept of "Oxidant-Antioxidant Balance"; IX. Concluding Remarks; References; Chapter 5. Pharmacological Implications of Interleukin-5 in the Control of Eosinophilia; I. Introduction; II. Biochemistry of Interleukin-5; III. Biological Properties of Interleukin-5.
- IV. Control of EosinophiliaV. Eosinophils and Tumors; VI. Eosinophils and Asthma; VII. Summary and Overview; References; Chapter 6. Advances in Antiarrhythmic Drug Therapy; I. Introduction; II. Classification of Antiarrhythmic Drugs; III. Applications of Classification Systems; IV. Class I Antiarrhythmic Drugs; V. Class II Antiarrhythmic Drugs; VI. Class III Antiarrhythmic Drugs; References; Chapter 7. New Developments in Thrombolytic Therapy; I. Introduction; II. Currently Available Plasminogen Activators; III. Antibody-Directed Thrombolysis.
- LV. Plasminogen Plus Plasminogen Activator CombinationsV. Thrombolysis and Anticoagulation; VI. Thrombolysis and Platelets; VII. Combinations of Plasminogen Activators; VIII. Summary; References; Chapter 8. Therapy of Hematopoietic Disorders with Recombinant Colony-Stimulating Factors; I. Overview of Normal Hematopoiesis; II. Pharmacologic Principles of Colony-Stimulating Factor Therapy; III. Clinical Uses of Colony-Stimulating Factors; Refcrences; Chapter 9. Mechanisms of Xenobiotic-Induced Renal Carcinogenicity; I. Introduction; II. Anatomy, Physiology, and Biochemistry of the Kidney.